HomeUromedica Inc.

Uromedica Inc.

Uromedica Announces the Initiation of its FDA Investigational Device Exemption Trial for ACT® to Evaluate its Safety and Efficacy for RX of SUI

Uromedica notes the investigational intent of the ACT trial, a post-operatively adjustable, minimally invasive outpatient procedure, is to assess safety and efficacy for women who suffer from moderate or severe SUI.